Compounded semaglutide
Sold by Care Clinics · Injection, vial · every compounded semaglutide record
Recorded initial charges
Initial payment · 3-month plan
$299
Monthly equivalent
$99.67
initial payment (3-month medication term), including required fees on record. The monthly equivalent is not a monthly bill. It combines the advertised medication rate with any recorded monthly membership and excludes one-time and annual fees. Renewal charges are not established by that figure. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · 3-month program, includes medication · recorded upfront charge for 3 months | $299 |
|---|
Added from the figures recorded below.
Price
| Term | Published rate | Charged today |
|---|---|---|
| 7-week program (standard states), includes medication “GLP-1 7weeks Includes medication 259 $” | $259Per 7 weeks | Charged today$259 |
| 7-week program, California “Only for $259 Only for $329 California Include 7 weeks medication” | $329Per 7 weeks | Charged today$329 |
| 3-month program, includes medication “GLP-1 3month Includes medication 299 $” | Per month$99.67 | Charged today$299 |
| Extended plan, any of the listed doses, flat rate “GLP-1 Extended Plan 1 mg for 20 weeks for $499 1.5 mg for 16 weeks for $499 1.75 mg for 14 weeks for $499 2 mg for 12 weeks for $499 2.5 mg for 10 weeks for $499” | Per month$99.80 | Charged today$499 |
Price sources
- 7-week program (standard states), includes medication · careclinics.us — read September 2026
- 7-week program, California · careclinics.us — read September 2026
- 3-month program, includes medication · careclinics.us — read September 2026
- Extended plan, any of the listed doses, flat rate · careclinics.us — read September 2026
We earn nothing from this link. It opens Care Clinics's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| States | 31 states (plus the District of Columbia): Texas, Florida, California, Oklahoma, Louisiana, Arkansas, Alabama, Georgia, Arizona, Massachusetts, Pennsylvania, Colorado, New Mexico, Idaho, Wyoming, Illinois, Ohio, Minnesota, Michigan, Connecticut, District of Columbia, Mississippi, New Hampshire, New Jersey, Washington, New York, Hawaii, Tennessee, Delaware, Indiana, Kentucky, and Wisconsin |
|---|---|
| Prescriber | Live visit |
| Cancellation | How can I cancel appointment? Call the number provided under contact us or email to the email address provided under contact us to cancel appointment. |
Not yet checked: pharmacy, membership and consult fee.
Recorded from careclinics.us. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Prices contradict between the homepage and the individual product pages for the GLP-1/GIP (tirzepatide) program: homepage lists 4-week at $299 and 3-month at $349, while the tirzepatide product page lists the same plans at $329 and $399 respectively. Both figures are recorded above as separate price entries with their own quotes/URLs; the register should flag this as an unresolved discrepancy rather than pick one. FAQ states a non-refundable $40 deposit is required to book a consultation slot, which 'goes towards final pricing.' FAQ also describes a 6-month extended tirzepatide plan (5mg/$999, 7.5mg/$1299, 10mg/$1599, 12.5mg/$1599) not fully captured above; see https://careclinics.us/faq/ for the complete list. Tirzepatide form (vial vs. pen) was never stated on any page checked, unlike semaglutide which the FAQ explicitly calls '1 vial.'
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.